Stocks and Investing
Stocks and Investing
Fri, August 4, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Luke Sergott Maintained (TXG) at Buy with Increased Target to $66 on, Aug 4th, 2023
Luke Sergott of Barclays, Maintained "10x Genomics, Inc." (TXG) at Buy with Increased Target from $65 to $66 on, Aug 4th, 2023.
Luke has made no other calls on TXG in the last 4 months.
There are 5 other peers that have a rating on TXG. Out of the 5 peers that are also analyzing TXG, 0 agree with Luke's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Luke
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $30 on, Thursday, July 13th, 2023
- Mason Carrico of "Stephens & Co." Reiterated at Buy and Held Target at $65 on, Thursday, May 18th, 2023
- Dan Brennan of "TD Cowen" Maintained at Buy with Increased Target to $66 on, Thursday, May 4th, 2023
- Daniel Arias of "Stifel" Maintained at Strong Buy with Increased Target to $68 on, Thursday, May 4th, 2023
- Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $65 on, Thursday, May 4th, 2023
Contributing Sources